WHO classifies three widely used medicines, including a common BP drug, as Group 1 carcinogens

The WHO's cancer research agency has classified Hydrochlorothiazide, Voriconazole and Tacrolimus as Group 1 carcinogens based on scientific evidence. Health experts, however, stress that patients should continue prescribed treatment and con